Anti-Voltage gated potassium channels (IgM)

Optimal result: 0 – 10 Units

The Anti-Voltage Gated Potassium Channels (VGKC) IgM test is a diagnostic assay aimed at detecting IgM antibodies targeting components of the VGKC complex. These channels are essential for regulating potassium ion flow in neurons, contributing to nerve signaling and maintaining the electrical activity of the nervous system.

What It Measures

This test specifically identifies IgM antibodies directed against VGKC-complex proteins. While IgG antibodies are more commonly associated with autoimmune neurological conditions, the presence of IgM antibodies may indicate an early immune response targeting these channels. The VGKC complex includes proteins such as leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein 2 (CASPR2), which are crucial for synaptic function and neuronal communication.

Clinical Relevance

Anti-VGKC IgM antibodies are less frequently studied compared to their IgG counterparts, but their detection could still provide insights into autoimmune mechanisms affecting the nervous system. VGKC-complex antibodies have been implicated in conditions such as:

  • Limbic Encephalitis: Characterized by cognitive impairment, seizures, and psychiatric symptoms, often associated with LGI1 antibodies.

  • Neuromyotonia: A peripheral nerve hyperexcitability syndrome linked to CASPR2 antibodies.

  • Morvan Syndrome: A rare disorder featuring neuromyotonia, autonomic dysfunction, and insomnia.

The Anti-Voltage Gated Potassium Channels (VGKC) IgM test is a diagnostic assay aimed at detecting IgM antibodies targeting components of the VGKC complex. These channels are essential for regulating potassium ion flow in neurons, contributing to nerve signaling and maintaining the electrical activity of the nervous system.

What It Measures

This test specifically identifies IgM antibodies directed against VGKC-complex proteins. While IgG antibodies are more commonly associated with autoimmune neurological conditions, the presence of IgM antibodies may indicate an early immune response targeting these channels. The VGKC complex includes proteins such as leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein 2 (CASPR2), which are crucial for synaptic function and neuronal communication.

Clinical Relevance

Anti-VGKC IgM antibodies are less frequently studied compared to their IgG counterparts, but their detection could still provide insights into autoimmune mechanisms affecting the nervous system. VGKC-complex antibodies have been implicated in conditions such as:

  • Limbic Encephalitis: Characterized by cognitive impairment, seizures, and psychiatric symptoms, often associated with LGI1 antibodies.

  • Neuromyotonia: A peripheral nerve hyperexcitability syndrome linked to CASPR2 antibodies.

  • Morvan Syndrome: A rare disorder featuring neuromyotonia, autonomic dysfunction, and insomnia.

Interpretation of Results

  • Positive Test Result: Indicates an autoimmune response targeting VGKC-complex proteins. This may suggest conditions like autoimmune encephalitis or neuromyotonia. However, IgM results should be interpreted cautiously as they are less specific than IgG results.

  • Negative Test Result: Reduces the likelihood of VGKC-complex-related disorders but does not rule out other autoimmune or neurological conditions.

Conclusion

While the Anti-VGKC IgM test is less commonly utilized than assays for IgG antibodies, it may provide supplementary information in diagnosing autoimmune neurological disorders. Further research is needed to clarify its clinical significance and role in disease mechanisms.

Anti-Voltage gated potassium channels (IgM)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Anti-Voltage gated potassium channels (IgM) — 10,000+ markers explained
One Anti-Voltage gated potassium channels (IgM) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro